The Future of Health Economics

Olivier Ethgen, Ulf Staginnus

$326

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Routledge
21 October 2016

Economics; Economics of industrial organisation; Investment & securities; International business; Manufacturing industries

The pharmaceutical industry faces a well-documented perfect storm: on the one hand, the patent cliff; the lack of new blockbusters and, on the other, economic pressure on pricing from markets with growing expectations and shrinking budgets. In the face of such pressure, traditional health economics models no longer seem appropriate and yet what do we have to replace them? The growing focus on 'value' and 'cost effectiveness' are evidence of new emerging thinking although, even here, with the shift from medicine as cure to medicine as palliative, as a treatment for chronic illness and with the growing emphasis on preventative approaches, the landscape is complex and challenging.

The Future of Health Economics offers a window into some of the most influential emerging issues in pharmacoeconomics; issues such as risk-sharing and alternative pricing models or the potential impact of radical new approaches such as personalized medicine; as well as exploring the changing role of government and regulators.

Ulf Staginnus and Olivier Ethgen, themselves two of the most well-regarded practitioners in this field, have brought together some leading-edge thinkers from industry and academia around the world to provide the industry, policy-makers, regulators, health practitioners and academics with the raw material for their future scenarios.

Edited by: Olivier Ethgen, Ulf Staginnus
Imprint: Routledge
Country of Publication: United Kingdom
Edition: New edition
Dimensions: Height: 246mm, Width: 174mm,
Weight: 660g
ISBN: 9781409445432
ISBN 10: 1409445437
Pages: 306
Publication Date: 21 October 2016
Audience: College/higher education , General/trade , Primary , ELT Advanced
Format: Hardback
Publisher's Status: Active

Olivier Ethgen is an international expert on modeling and risk sharing agreements. He has an academic post at the Universite de Liege, and is a modeling consultant for GSK Biologicals. He holds a PhD in Public Health Sciences from Universite de Liege and an MSc in Mathematical Economics and Econometrics from Universite Pantheon Sorbonne (Paris I). Ulf Staginnus is Head of Health Economics & Outcome Research Europe at Novartis Oncology and author of the Health Economics blog www.healtheconomicsblog.com.